181 related articles for article (PubMed ID: 15900339)
1. Stereoselective hydroxylation of an achiral cyclopentanecarboxylic acid derivative using engineered P450s BM-3.
Münzer DF; Meinhold P; Peters MW; Feichtenhofer S; Griengl H; Arnold FH; Glieder A; de Raadt A
Chem Commun (Camb); 2005 May; (20):2597-9. PubMed ID: 15900339
[TBL] [Abstract][Full Text] [Related]
2. Regio- and enantioselective alkane hydroxylation with engineered cytochromes P450 BM-3.
Peters MW; Meinhold P; Glieder A; Arnold FH
J Am Chem Soc; 2003 Nov; 125(44):13442-50. PubMed ID: 14583039
[TBL] [Abstract][Full Text] [Related]
3. Engineered alkane-hydroxylating cytochrome P450(BM3) exhibiting nativelike catalytic properties.
Fasan R; Chen MM; Crook NC; Arnold FH
Angew Chem Int Ed Engl; 2007; 46(44):8414-8. PubMed ID: 17886313
[No Abstract] [Full Text] [Related]
4. Are branched chain fatty acids the natural substrates for P450(BM3)?
Cryle MJ; Espinoza RD; Smith SJ; Matovic NJ; De Voss JJ
Chem Commun (Camb); 2006 Jun; (22):2353-5. PubMed ID: 16733577
[TBL] [Abstract][Full Text] [Related]
5. Laboratory evolution of cytochrome p450 BM-3 monooxygenase for organic cosolvents.
Wong TS; Arnold FH; Schwaneberg U
Biotechnol Bioeng; 2004 Feb; 85(3):351-8. PubMed ID: 14748091
[TBL] [Abstract][Full Text] [Related]
6. Protein engineering of the cytochrome P450 monooxygenase from Bacillus megaterium.
Urlacher VB; Schmid RD
Methods Enzymol; 2004; 388():208-24. PubMed ID: 15289074
[No Abstract] [Full Text] [Related]
7. A continuous spectrophotometric assay for P450 BM-3, a fatty acid hydroxylating enzyme, and its mutant F87A.
Schwaneberg U; Schmidt-Dannert C; Schmitt J; Schmid RD
Anal Biochem; 1999 May; 269(2):359-66. PubMed ID: 10222011
[TBL] [Abstract][Full Text] [Related]
8. Expression, purification, and characterization of Bacillus subtilis cytochromes P450 CYP102A2 and CYP102A3: flavocytochrome homologues of P450 BM3 from Bacillus megaterium.
Gustafsson MC; Roitel O; Marshall KR; Noble MA; Chapman SK; Pessegueiro A; Fulco AJ; Cheesman MR; von Wachenfeldt C; Munro AW
Biochemistry; 2004 May; 43(18):5474-87. PubMed ID: 15122913
[TBL] [Abstract][Full Text] [Related]
9. Progress towards the easier use of P450 enzymes.
Chefson A; Auclair K
Mol Biosyst; 2006 Oct; 2(10):462-9. PubMed ID: 17216026
[TBL] [Abstract][Full Text] [Related]
10. Improving catalytic properties of P450 BM3 haem domain electrodes by molecular Lego.
Fantuzzi A; Meharenna YT; Briscoe PB; Sassone C; Borgia B; Gilardi G
Chem Commun (Camb); 2006 Mar; (12):1289-91. PubMed ID: 16538250
[TBL] [Abstract][Full Text] [Related]
11. Enantioselective alpha-hydroxylation of 2-arylacetic acid derivatives and buspirone catalyzed by engineered cytochrome P450 BM-3.
Landwehr M; Hochrein L; Otey CR; Kasrayan A; Bäckvall JE; Arnold FH
J Am Chem Soc; 2006 May; 128(18):6058-9. PubMed ID: 16669674
[TBL] [Abstract][Full Text] [Related]
12. P450BM-3: absolute configuration of the primary metabolites of palmitic acid.
Truan G; Komandla MR; Falck JR; Peterson JA
Arch Biochem Biophys; 1999 Jun; 366(2):192-8. PubMed ID: 10356283
[TBL] [Abstract][Full Text] [Related]
13. Filling a hole in cytochrome P450 BM3 improves substrate binding and catalytic efficiency.
Huang WC; Westlake AC; Maréchal JD; Joyce MG; Moody PC; Roberts GC
J Mol Biol; 2007 Oct; 373(3):633-51. PubMed ID: 17868686
[TBL] [Abstract][Full Text] [Related]
14. Use of kinetic isotope effects to delineate the role of phenylalanine 87 in P450(BM-3).
Rock DA; Boitano AE; Wahlstrom JL; Rock DA; Jones JP
Bioorg Chem; 2002 Apr; 30(2):107-18. PubMed ID: 12020135
[TBL] [Abstract][Full Text] [Related]
15. Altering the regioselectivity of the subterminal fatty acid hydroxylase P450 BM-3 towards gamma- and delta-positions.
Dietrich M; Do TA; Schmid RD; Pleiss J; Urlacher VB
J Biotechnol; 2009 Jan; 139(1):115-7. PubMed ID: 18984016
[TBL] [Abstract][Full Text] [Related]
16. Thermal equilibrium of high- and low-spin forms of cytochrome P450 BM-3: repositioning of the substrate?
Jovanovic T; Farid R; Friesner RA; McDermott AE
J Am Chem Soc; 2005 Oct; 127(39):13548-52. PubMed ID: 16190718
[TBL] [Abstract][Full Text] [Related]
17. Laboratory evolution of P450 BM-3 for mediated electron transfer.
Nazor J; Schwaneberg U
Chembiochem; 2006 Apr; 7(4):638-44. PubMed ID: 16521141
[TBL] [Abstract][Full Text] [Related]
18. Preparative use of isolated CYP102 monooxygenases -- a critical appraisal.
Eiben S; Kaysser L; Maurer S; Kühnel K; Urlacher VB; Schmid RD
J Biotechnol; 2006 Aug; 124(4):662-9. PubMed ID: 16716428
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure of inhibitor-bound P450BM-3 reveals open conformation of substrate access channel.
Haines DC; Chen B; Tomchick DR; Bondlela M; Hegde A; Machius M; Peterson JA
Biochemistry; 2008 Mar; 47(12):3662-70. PubMed ID: 18298086
[TBL] [Abstract][Full Text] [Related]
20. Selective hydroxylation of highly branched fatty acids and their derivatives by CYP102A1 from Bacillus megaterium.
Budde M; Morr M; Schmid RD; Urlacher VB
Chembiochem; 2006 May; 7(5):789-94. PubMed ID: 16566047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
